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Despite the low frequency, port-site metastases are associated with poor outcomes in patients and ac-
count for signiﬁcant patient morbidity. They remain a challenging complication of laparoscopic pro-
cedures for gynecologic malignancies. A comprehensive, systematic search for published studies was
conducted using the PubMed databases. Various mechanisms of port-site metastases are addressed in
the relevant literature. The review of the articles points out that in the development of port-site me-
tastases, the major role is played by biologically aggressive diseases, tumor manipulation, wound
contamination, and surgery-related factors. The advantages of laparoscopic oncologic surgery are un-
questionable. Further investigations of the mechanisms of port-site metastasis would contribute to the
prevention of this insidious pathology.
Copyright © 2015, The Asia-Paciﬁc Association for Gynecologic Endoscopy and Minimally Invasive
Therapy. Published by Elsevier Taiwan LLC. All rights reserved.Introduction
Laparoscopic surgery has been used for treatment of oncological
patients for the past 30 years. The ﬁrst reports concerning lapa-
roscopy implementation in oncogynecology date back to the
1970s.1e3 It is undebatable that laparoscopic surgery has numerous
advantages. It affords a safe and less invasive modality for both
diagnostic and major operative procedures.4 Its safety and feasi-
bility have been proved by numerous authors, who published their
experience with total laparoscopic radical hysterectomy.5e7
Laparoscopy has several signiﬁcant advantages in oncologic
patients.8e14 Oncologic and immunologic functions are much bet-
ter preserved after laparoscopic surgery.15e17 Additionally, speciﬁc
to gynecologic malignancies, shorter intervals to postoperative
treatments can also be listed as advantages to minimally invasives of interest.
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for Gynecologic Endoscopy and Minimsurgery.18 Patients who undergo minimally invasive surgery can
often begin adjuvant therapy relatively quickly after their initial
surgery because of the shorter recovery time.19
As main complications of laparoscopic oncology, the authors
mention vascular injuries, bowel injuries, genitourinary injuries,
and port-site metastases (PSMs).20,21 Nevertheless, Chi et al22
found that both simple and complex laparoscopic procedures can
be performed by a gynecologic oncology service with a low rate of
complications. Among the mentioned complications, we consider
PSMs rather important in laparoscopic oncology. Also, it should be
underlined that PSM is a strong risk factor for peritoneal dissemi-
nation.23 PSMs are associated with poor outcome of patients24 and
represent signiﬁcant patient morbidity and end-of-life care is-
sues.25 All the above-mentioned factors highlight the high actuality
of PSMs in today's laparoscopic surgery (Figure 1).
Incidence
The ﬁrst paper describing the case of developing local tumor
metastases after laparoscopy was presented by D€obr€onte et al26 in
1978. Following that, numerous data regarding this complication
have been published in various surgical specialties. Zivanovically Invasive Therapy. Published by Elsevier Taiwan LLC. All rights reserved.
Figure 1. Arrow shows tumor metastasis over fascia and subcutaneous tissue. The
overlying skin and parietal peritoneum are intact.
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mented in 20 of 1694 patients (1.18%) who underwent laparoscopic
procedures for a malignant intra-abdominal condition. In the
investigation of Nagarsheth et al,28 83 patients with endometrial
(39), ovarian (29), and cervical (14) cancers were subjected to
laparoscopic treatment. The overall incidence of PSMs in gyneco-
logic cancers in that was 2.3%. In the study of Martinez et al,29 1216
laparoscopic procedures were performed in women with endo-
metrial end uterine cancers, and the incidence of PSM after lapa-
roscopy for cervical and endometrial cancer was 0.43% and 0.33%,
respectively.29 Rassweiler et al30 found an incidence of 0.18% in
1098 patients who had undergone laparoscopic procedures for
urologic malignancies. Shoup et al31 examined the incidence of
PSMs for upper gastrointestinal tract malignancies and found that
port-site implantation after laparoscopic procedures occurred in
0.79% of 1650 patients. Fleshman et al32 noted an incidence of PSM
in 0.9% in 435 patients who underwent laparoscopic-assisted
colectomy. Summarizing, Terence et al24 reviewed 17 studies,
which included 11,027 cancer patients undergoing laparoscopic
surgery or diagnostic laparoscopy, and pointed out that PSM is a
rare phenomenon, occurring in less than 2% of patients.
Immune response
Data concerning immune response in the development of PSMs
are rather rare. However, among the existing ones, the study of Ost
et al33 is of interest. In their study, mice and the syngenic murine
bladder tumor cell line were used. The investigators subjected mice
to either CO2 pneumoperitoneum or midline incision. Peritoneal
macrophageswere collected. The tumor necrosis factor (TNF)-alpha
levels were quantiﬁed. As the conclusion, the study showed that in
a syngenic murine model, CO2 pneumoperitoneum causes inhibi-
tion of peritoneal macrophage TNF-alpha secretion. Inhibition of
peritoneal macrophage TNF-alpha secretion may be considered an
adverse event contributing to the development of transitional-cell
carcinoma PSM, especially if surgical oncologic principles are
violated. Prior to this study, Gupta and Watson34 reviewed the
literature on immunological changes following laparoscopy and
open surgery from Medline and concluded that despite a few
contradictory reports, systemic immunity appears to be better
preserved after laparoscopic surgery than after open surgery.
However, the local intraperitoneal immune system behaves in a
particular way when exposed to carbon dioxide pneumo-
peritoneum; suppression of intraperitoneal cell-mediated immu-
nity has been demonstrated in a number of studies.34 In addition tothe abovementioned studies, Kuhry et al,35 in their review article,
argue that although laparoscopic surgery for colorectal malig-
nancies may be associated with higher survival rates and lower
recurrence rates because of improved immune function, it has also
been related to high incidences of PSMs. Reviews in the literature
have now shown that incidences of PSMs are comparable to in-
cidences of wound metastases after open surgery.35 Moreover, in
their review article, “Immunological aspects of minimally invasive
oncologic surgery,” Hegarty and Dasgupta36 summarized that lap-
aroscopy results in better overall preservation of immune function
than open surgery. Also, a substantial number of recent studies on
the topic of immune response in general and gynecologic surgery
were identiﬁed fromMedline by Holub,37 with a conclusion stating
that laparoscopic surgery better preserves the postoperative
immunological functions compared with the open approach.
Nevertheless, Ost et al,33 Kuhry et al,35 Hegarty and Dasgupta,36
and Holub37 (referred by our group), as well as other inves-
tigators,38e40 share a common opinion that the status of the im-
mune response in laparoscopic procedures and its contribution in
future development of the PSMs needs to be further investigated.
Pneumoperitoneum
Some investigations showed stimulation of tumor growth by
intra-abdominal pressure.40e43 Different pressures and their effect
on tumor growth and PSMs in a rat model both in vivo and in vitro
were investigated by Jacobi et al,40 who showed that tumor cells
incubated with CO2 at 10 and 15 mmHg revealed a decreased
in vitro intraperitoneal tumor growth in comparisonwith pressures
at 0 and 5mmHg. As for the studies in vivo, increased tumor growth
could be observed at laparoscopy at 5 and 10mmHg comparedwith
the control group. Increase of subcutaneous tumor growth was
observed at laparoscopy at 5, 10, and 15 mmHg compared with
controls.44 Nevertheless, other data demonstrated the stimulation
of intra-abdominal tumor growth caused by high-pressure CO2 and
leading to increased pulmonary metastasis.42
Moreira etal45 reported that as a result of insufﬂating gas'
distension of abdomen, a high pneumperitoneal pressure is
created, which in turn provokesmovement of free peritoneal tumor
cells, or may cause sloughing or dissemination of tumor cells from
viscera into the peritoneal cavity. An increased blood ﬂow of the
anterior abdominal wall caused by intra-abdominal high pressure
as a result of pneumoperitoneum can be a possible risk factor of
PSMs because of the increased circulation.46
Carbon dioxide is the most commonly used gas for insufﬂations
during laparoscopic surgery. It is nonﬂammable, inexpensive,
colorless, readily available, and readily absorbed.47 There are
several conﬂicting results regarding intraperitoneal tumor growth
as a result of CO2 pneumoperitoneum. In particular, Jingli et al48
presented a study where intraoperative peritoneal lavage
cytology was performed for 36 patients with colorectal cancer
during colorectal laparoscopic surgery and for 45 patients with
colorectal cancer during conventional surgery. Cytology was
examined twice: immediately after opening of the peritoneal cavity
and just prior to closure of the abdomen. Malignant cells were not
detected in the CO2 ﬁltrate gas. The incidence of positive cytology in
the lavage of the instruments during laparoscopic surgery was
2.78%. The incidence of positive cytology during laparoscopic sur-
gery was 33.33% in the prelavage and 8.33% in the postlavage. The
incidence of positive cytology during conventional surgery was
33.33% in the prelavage and 11.11% in the postlavage. The conclu-
sion was that during colorectal laparoscopic surgery, CO2 pneu-
moperitoneum does not affect tumor cell dissemination and
seeding.48 In this study, laparoscopic techniques used in colorectal
cancer surgery were not associated with a greater risk for
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technique. Ishida et al42 came to a similar conclusion after per-
forming an investigation on rabbits, wherein the presence of a
trocar may be a factor contributing to PSM, but CO2 pneumo-
peritoneum appears not to be a factor.
Controversial data were presented by Hirabayashi et al,49 who
performed a study on 15 nude mice, which were injected with
human gastric cancer (MKN 45) cells with further determining of
the effect of pneumoperitoneum by using a scanning electron mi-
croscope to study the effects of how tumor cells disseminate to
form PSMs after pneumoperitoneum. They found that pneumo-
peritoneum immediately results in peeling and destruction of the
muscular layer of the abdominal peritoneum, increasing the pro-
pensity of tumor cell adhesion at port sites and subsequently
healing process occurs, leading to scar formationwith the presence
of entrapped tumor cells. The conclusion of the study was that free
cancer cells appear to attach to the injured port sites immediately
after CO2 pneumoperitoneum, and these are associated with the
development of PSM after laparoscopic cancer surgery.49
Furthermore, the type of gas has also been shown to inﬂuence
the rates of PSM with helium insufﬂations being the least likely
compared to argon and nitrogen, which were more likely to be
associated with PSM.50Wound contamination
According to some authors, the tumor cell entrapment hy-
pothesis is one of the etiologic development factors of the PSM. The
essence of this hypothesis, presented in 1989, is that free cancer
cells are capable of implanting on raw tissue surfaces including
damaged peritoneal surfaces.51 The tumor cells' destruction by the
normal defense mechanisms could be prevented by ﬁbrinous ex-
udates that cover the raw tissue surfaces including damaged peri-
toneal surfaces in the postoperative period.
In laparoscopic procedures, the specimen is often extracted
through a small wound that can increase tissue trauma, which may
play a role in wound implantation.52,53 The extraction of tumor
through a small port site together with the leakage of CO2 that
occurs may induce movement of free tumor cells that have an
increased propensity to implant in the traumatized tissue of the
wound.53 During the surgical procedure, ongoing passage and
extrication of instruments that are contaminated by tumormaterial
owing to the dissection process, may also explain its occurrence.24
Up to 70% of animal studies revealed tumor cell deposition in
extraction wounds.54 The survey of Paolucci et al55 demonstrated
that 55% of PSMs were found at the extraction port. Nevertheless,
the same study also showed that an extraction bag was used in
11.5% of the patients who developed metastases at the extraction
wound. The fact that PSM can be caused by other etiologic factors is
proved in the same study. Although direct wound implantation
likely plays a major role, there clearly are other etiologic factors
because direct wound implantation does not explain the other 40%
of patients who develop metastatic disease at nonextraction port
sites. Another common port site where metastatic disease can be
found is the operating port. Allardyce et al56,57 found more tumor
cells at operating ports than at assistants' ports, which suggested
that wound implantation was caused by contamination of in-
struments. The studies show that concentration of the tumor cells
inwoundwashings goes as high as 26% and that the tumor cells are
able to recover from the gloves and instruments used during sur-
gery.58 Numerous investigators have shown instrument contami-
nation with malignant cells.52,56,59,60 Instrument contamination
can occur by direct implantation of cancer cells after specimen
manipulation. These cells can then contaminate the trocars, leadingto PSMs.54 Frequent changes of instruments may predispose to
tumor wound implantation.52,57
It should be underlined that although conﬂicting data exist from
animal and human studies, a general trend is observed toward
systemic immune preservation and peritoneal immune depression
during insufﬂation-based laparoscopy. This altered peritoneal im-
mune response could also be an adverse event contributing to the
rare development of PSMs.
Tumor-related factors
There are several postulated causes for developing PSMs; of
these, tumor aggressiveness appears to be the most favored. It is a
truism of cancer biology that the more aggressive the tumor in
terms of grade and stage, the more likely that tumor is to metas-
tasize. Thus, the phenomenon of PSMs might simply reﬂect the
biological aggressiveness of the primary tumor.61
In their article, “Risk factors contributing to early occurrence of
port-site metastases of laparoscopic surgery for malignancy,”Wang
et al62 discovered that the majority of recurrences were in patients
with adenocarcinoma cell type, advanced stage (far-advanced dis-
ease), and often with diffuse peritoneal carcinomatosis, and,
consequently, concluded that PSMs may contribute to the highly
aggressive nature of the disease.62 We can meet practically the
same conclusion in Abu-Rustum et al's63 studydsubcutaneous
implantation appears to occur in patients with known metastatic
disease and is detected in the setting of synchronous advanced
intra-abdominal or pelvic metastasis and progression of
carcinomatosis.
In spite of this, in a review article that analyzed 31 articles,
which included 58 patients, Ramirez et al,64 concluded that lapa-
roscopic PSMs are a potential complication of laparoscopy in pa-
tients with gynecological malignancies, even in patients with early-
stage disease. Meanwhile, Zivanovic et al27 analyzed a prospective
database of all patients undergoing transperitoneal laparoscopic
procedures for malignant conditions performed by the gynecologic
oncology service, in which 2251 patients were involved. The in-
vestigators arrived at a conclusion that the rate of port-site tumor
implantation after laparoscopic procedures in women with malig-
nant disease is low and almost always occurs in the setting of
synchronous, advanced intra-abdominal or distant metastatic dis-
ease.12 Moreover, Rassweiler et al30 performed 1098 laparoscopic
procedures for urological malignancies, and concluded that ac-
cording to their experience the incidence of local recurrence and
the risk of PSMs is low and seems to be mainly related to the
aggressiveness of the tumor.
Martinez et al29 estimated the incidence of clinically detected
PSMs in patients with endometrial and cervical cancer treated at
two gynecologic oncology services with extensive experience.
During the study period, 1216 laparoscopic procedures for uterine
cancer were performed. A total of 921 patients underwent laparo-
scopic staging for cervical cancer and 295 for endometrial cancer.
The overall incidence of PSM in our institutions was 0.4% per pro-
cedure (5 patients), and the incidence of PSM after laparoscopy for
cervical and endometrial cancer was 0.43% and 0.33%, respectively.
Excluding patients with peritoneal carcinomatosis, the rate of port-
site recurrence in our series lowered to 0.16%, and the rate of iso-
lated PSMs dropped to 0%. The median time to the development of
PSM was 8 months (range 6e48), the median overall survival from
diagnosis for all patients was 26 months (range 7e30), and median
survival from recurrence was 5 months (range 1e20). They
concluded that although PSMs are recognized as a complication of
laparoscopy for ovarian cancer, they are a rare complication of
laparoscopic staging for endometrial and cervical cancer. The ma-
jority of patients with PSM presented with associated synchronous
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roscopy in patients with advanced ovarian carcinoma, as well. In
addition to the abovementioned studies, there is a very interesting
investigation byNagarsheth et al,28 in which they determined the
incidence of PSMs in patients undergoing laparoscopic procedures
for gynecologic cancers. The charts of patients treated by laparos-
copy for diagnosis, treatment, or staging of gynecologic cancer were
studied. No patients without a histological or cytological diagnosis
of cancer from the index procedure were included. Fisher's exact
test was used for statistical analysis. Eighty-three patients were
identiﬁed accounting for 87 procedures. The types of cancer treated
included endometrial (39), ovarian (29), and cervical (14). Twenty
procedures were performed for recurrence of ovarian or peritoneal
cancer, and ascites was present in 10 cases. The conclusionwas that
the overall incidence of PSMs in gynecologic cancers in their study
was 2.3%. The risk of PSMs is highest (50%) in patients with recur-
rence of ovarian or primary peritoneal malignancies undergoing
procedures in the presence of ascites.28 Along with this, the study
by Obermair et al66 is also noteworthy. The given study is a retro-
spective review of patients presenting with stages 1e4 endometrial
cancer, who had a hysterectomy, bilateral salpingo-oophorectomy
with or without surgical staging. The surgical intent was total
laparoscopic hysterectomy (TLH) in 226 patients (44.3%) and total
abdominal hysterectomy (TAH) in 284 patients (55.7%). The
conclusion was that the incidence of PSM in early-stage endome-
trial cancer treated by TLH is low.66
Surgical technique
One of the primary reasons for PSM occurrence is the surgical
technique used. In the development of PSM, spillage or liberation of
cells from the primary tumor has one of the key roles; therefore,
handling of tumor during laparoscopy is rather important.67e69
There are several interesting studies performed by Lee et al70 at
different times. One of the studies involved female mice that un-
derwent crushing of a subcapsular splenic tumor during laparo-
scopic exploration. The scope of port site involvement in thesemice
was very high in comparison with those that did not undergo tu-
mor crashing. In the same animal model, the authors found that
surgical technique may be a possible factor in port tumor forma-
tion. They also noted that PSMs decreased with surgeon experi-
ence,71 and wound recurrence may actually be the result of an
unfortunate learning curve.72
Polat et al,73 in their experimental study in rats, referred to the
effect of types of resection and manipulation on trocar site
contamination after laparoscopic colectomy. The investigators
detected and quantiﬁed the amount of contamination at the port-
site by means of a method utilizing radiolabeled colloid particles
following extra- or intracorporeal laporoscopic resection of cecum.
Prior to the experimental surgery, they obtained a high concen-
tration of luminal colonic radiotracer activity by per anum appli-
cation of sulfur colloid molecules labeled with Tc-99m
pertechnetate. In three main groups of rats, they either resected a
portion of cecum extracorporeally or intracorporeally, or did no
resection at all. Each main group was further divided into two
subgroups, in which the manipulations were either atraumatic or
traumatic. They excised trocar sites as 2-cm doughnuts after
completion of the surgical procedure. Gamma camera imaging to
quantify the amount of radioactive contamination at trocar sites
was used. We detected an overall incidence of contamination in
44% of rats. This rate was 71% and 17% in traumatic and atraumatic
subgroups. The resection itself increased the rate and intensity of
contamination as well (p ¼ 0.04). The most intensive contamina-
tion was detected in the intracorporeal resection with traumatic
manipulation subgroup.73 This study proves the signiﬁcance oftumor manipulation. PSM formation can be a result of tumor
extraction without the use of an entrapment sac or by direct
dissemination of tumor by contaminated instruments.30,67,74,75
The signiﬁcance of tumor manipulation during surgery in PSMs
is also proved by other studies. In a rat model study, Mathew et al76
presented an increased level of metastases due to tumor manipu-
lation in open and laparoscopic surgery. The randomized controlled
trial performed byMutter et al77 on rats also pointed out that tumor
manipulation is the main factor acting on tumor dissemination in
both laparoscopy and laparotomy. In the conclusion, the in-
vestigators also highlighted that the laparoscopic surgery had a
beneﬁcial effect on local tumor growth compared with laparotomy
in the case of tumor manipulation. This beneﬁcial effect of lapa-
roscopic surgery may be related to a better preservation of immune
function in the early postoperative period.77 Oncological safety of
the accurately implemented marcellation of the surgical specimen
referred to by many authors should be especially underlined.78e81
In addition, some literature review exists regarding the surgical
technique decreasing the risk of PSMs. In particular, Agostini et al82
showed in their investigation in rat models that peritoneal closure
decreases the risk of PSMs. Schneider et al,83 in their experimental,
prospective, randomized, single-blind study, investigated the in-
ﬂuence of quality surgery on the incidence of port-site recurrences
and concluded that trocar ﬁxation, prevention of gas leaks, rinsing
of instruments with povidoneeiodine, minilaparotomy protection,
rinsing of trocars prior to removal, peritoneal closure, and rinsing of
all wounds with povidoneeiodine during surgery decrease the risk
of PSMs.83
Conclusion
PSMs are seldom encountered. The etiology of PSMs is multi-
functional. Recurrence of PSMs is quite rare in endometrial and
cervical cancers treated laparoscopically. Nevertheless, a tangible
role in PSM incidence is attributed to ovarian cancer, primary
peritoneal cancer, presence of ascites and biologically aggressive
diseases, surgery-related factors including tumor manipulation and
wound contamination. Unquestionable advantages of laparoscopic
oncologic surgery should be highlighted. The following key factors
may decrease the incidence of PSMs: a surgeon's experience, cor-
rect and maximally atraumatical tumor manipulation and marcel-
lation, tumor removal from the vagina, use of an impermeable bag,
povidoneeiodine irrigation of the laparoscopic instruments, trocar,
and port site wounds, and suturing of 10 mm and larger trocar
wounds. In our opinion, further investigations of the mechanisms
of PSM would contribute to the prevention of this insidious
pathology.
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